Product analysis · serum · Naturium
Multi-Peptide Advanced Serum
Naturium Multi-Peptide Advanced Serum is positioned for lines, texture and hydration. This report separates current peptide and delivery-system claims from older feedback about hydration, feel and dispensing.
Hydration feedback and dispensing feedback point to different buying considerations: the selected historical packaging cell contains 27 negative and 3 positive mentions. This is not proof of a particular pump defect, current packaging performance or an individual result. The 30 ml and 60 ml options have no measured dose supporting a days estimate.
These are the five focal Notes from the Lab skin labels. They are manufacturer positioning, not an all-types safety claim or proof of personal tolerance. The saved mature/all-types metadata remains separate.
A skin-type label does not predict individual reactions.
The manufacturer positions its multi-peptide serum for texture, fine-line and wrinkle appearance, plus hydration and a lifted-looking effect. These are cosmetic brand claims; no independent comparative result or treatment conclusion is supplied.
Results and timing are brand claims, not guaranteed outcomes.
The focal page describes encapsulated copper peptides and Argireline Amplified peptide, encapsulated ferulic acid and collagen. It labels the current product fragrance-free and vegan. These are current manufacturer labels. The source warns that website, packaging and distributor ingredient lists can vary with updates and regional rules.
Historical formula and lot continuity remain unknown; brand delivery-system claims are not independently verified.
The corrected contributing source dates span October 7, 2023 to April 10, 2026. Targeted-concern mentions combine different named cosmetic endpoints and are not a wrinkle-reduction or firmness rate. General visible results remain a separate broad dimension.
- Concern-specific results: 17 positive · 0 negative · 17 classified mentions
- Hydration and plumping: 37 positive · 4 negative · 41 classified mentions
- General visible results: 9 positive · 4 negative · 13 classified mentions
Classified mentions in the retained subset; these counts are not ratings or unique buyers.
Historical sources through April 10, 2026; current manufacturer facts captured October 19, 2026. Counts are source/dimension mentions, not people, measured efficacy or personal-fit scores. Formula and retailer-pack continuity remain unverified.
Both directions are shown for skin comfort, formula feel and packaging. Formula feel is separate from a change in skin texture. Ingredient-quality coverage is below the ten-mention minimum; layering, scent and value are unselected. These aggregates do not identify a symptom or establish causality.
- Skin comfort and irritation: 16 positive · 17 negative · 33 classified mentions
- Absorption and formula feel: 42 positive · 3 negative · 45 classified mentions
- Packaging and dispensing: 3 positive · 27 negative · 30 classified mentions
Classified mentions in the retained subset; these counts are not ratings or unique buyers.
Broad feedback dimensions do not establish reaction rates, clinical safety or individual tolerance.
The source pairs Standard 1.0 FL OZ with 30 ML and Jumbo 2.0 FL OZ with 60 ML. These are two documented source options, not separate sizes created by conversion, a complete live range or selected retailer-pack detection. Directions say one to two pea-sized drops, spread over face, neck and chest, with AM/PM use and moisturizer.
Pea-sized drops are unmeasured; no bottle-life estimate or current availability is established.
Sources and dates
Source observation dates are shown separately from the editorial review date.
- Focal manufacturer family context, captured October 19, 2026 · Current brand information ·
- Historical retained feedback first contributing source · Historical feedback · retained subset ·
- Historical retained feedback last contributing source · Historical feedback · retained subset ·
First published: (Pacific time). Updated: (Pacific time). Editorial dates do not refresh historical evidence.
Full evidence and limits
- Current manufacturer family context captured October 19, 2026; contributing historical feedback ends April 10, 2026. Exact formula, lot and retailer-pack continuity remain unverified.
- Counts are source/dimension contributions, not independent buyers, measured efficacy, symptom rates or personal-fit scores.
- Historical formula and lot continuity remain unknown; brand delivery-system claims are not independently verified.
- Broad feedback dimensions do not establish reaction rates, clinical safety or individual tolerance.
- Pea-sized drops are unmeasured; no bottle-life estimate or current availability is established.